Study Data from Tokushima University Hospital Update Understanding of Rhabdomyolysis (Association Between Statin Use and Daptomycin-related Musculoskeletal Adverse Events: a Mixed Approach Combining a Meta-analysis and a Disproportionality...).

In the meta-analysis, statin use significantly increased the incidence of DAP-related rhabdomyolysis (odds ratio [OR]: 3.83; 95% confidence interval [CI]: 1.43-10.26) but not DAP-related myopathy (OR: 1.72; 95% CI:.95-3.12). Keywords: Tokushima; Japan; Asia; Adverse Drug Reactions; Antibiotics; Antiinfectives; Cyclic Peptides; Daptomycin Therapy; Drugs and Therapies; Health and Medicine; Lipopeptides; Muscular Diseases and Conditions; Musculoskeletal Diseases and Conditions; Myopathy; Nephrology; Peptides; Pharmaceuticals; Rhabdomyolysis EN Tokushima Japan Asia Adverse Drug Reactions Antibiotics Antiinfectives Cyclic Peptides Daptomycin Therapy Drugs and Therapies Health and Medicine Lipopeptides Muscular Diseases and Conditions Musculoskeletal Diseases and Conditions Myopathy Nephrology Peptides Pharmaceuticals Rhabdomyolysis 2325 2325 1 10/16/23 20231020 NES 231020 2023 OCT 20 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Research findings on Musculoskeletal Diseases and Conditions - Rhabdomyolysis are discussed in a new report. [Extracted from the article]